Literature DB >> 23335496

Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease.

Aziza Azimi1, Mette Gitz Charlot, Christian Torp-Pedersen, Gunnar H Gislason, Lars Køber, Lisette Okkels Jensen, Per Thayssen, Jan Ravkilde, Hans-Henrik Tilsted, Jens Flensted Lassen, Leif Thuesen.   

Abstract

OBJECTIVE: Obesity is paradoxically associated with enhanced survival in patients with established cardiovascular disease. We explored this paradox further by examining the influence of obesity on survival in patients with verified atherosclerotic heart disease. DESIGN AND PATIENTS: This retrospective registry based cohort study included all patients from the Western Denmark Heart Registry with coronary atherosclerosis confirmed by coronary angiography from January 2000 to December 2010. Patients were divided into eight groups according to body mass index (BMI) based on WHO BMI classification.
SETTING: Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark.
RESULTS: The study included 37 573 patients (70.7% men) with a mean age of (66.3 ± 11.1) years. During the 11 years of follow-up, 5866 (15.6%) patients died. Multivariable analysis confirmed that the risk of death was the lowest among the preobese patients (27.5 ≤ BMI<30 kg/m(2)) with adjusted HR of 0.82 (95% CI 0.71 to 0.95; p=0.008) and increased with both low (BMI<18.50 kg/m(2)) and very high (BMI ≥ 40 kg/m(2)) BMI, HR 2.04 (95% CI 1.63 to 2.57; p<0.001) and HR 1.35 (95% CI 1.05 to 1.72; p<0.01), respectively. Also the normal weight class I (18.5 ≤ BMI<23 kg/m(2)) had a significant risk of mortality HR 1.28 (95% CI 1.13 to 1.45; p<0.001). Obese classes I and II did not differ from the reference group (23 ≤ BMI<25 kg/m(2)).
CONCLUSIONS: Overweight atherosclerotic heart disease patients have improved survival compared with normal weight patients. Underweight and severely obese patients have increased mortality. Our results lean more towards an overweight paradox than an obesity paradox.

Entities:  

Mesh:

Year:  2013        PMID: 23335496     DOI: 10.1136/heartjnl-2012-303066

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  6 in total

Review 1.  Management of cardiovascular diseases in patients with obesity.

Authors:  Carl J Lavie; Ross Arena; Martin A Alpert; Richard V Milani; Hector O Ventura
Journal:  Nat Rev Cardiol       Date:  2017-07-27       Impact factor: 32.419

2.  Profile and Correlates of Health-related Quality of Life in Chinese Patients with Coronary Heart Disease.

Authors:  Ling Wang; Yi-Qun Wu; Xun Tang; Na Li; Liu He; Yang Cao; Da-Fang Chen; Yong-Hua Hu
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

3.  Prognostic significance of BMI after PCI treatment in ST-elevation myocardial infarction: a cohort study from the Swedish Coronary Angiography and Angioplasty Registry.

Authors:  Shabbar Jamaly; Bjorn Redfors; Elmir Omerovic; Lena Carlsson; Kristjan Karason
Journal:  Open Heart       Date:  2021-02

Review 4.  Molecular approaches in obesity studies.

Authors:  Mona Zamanian-Azodi; Reza Vafaee; Taghi Azodi; Roghiyeh Omidi; Samira Gilanchi; Farid Azizi-Jalilian; Reza Khodarahmi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

Review 5.  Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.

Authors:  Giorgio Ghigliotti; Chiara Barisione; Silvano Garibaldi; Patrizia Fabbi; Claudio Brunelli; Paolo Spallarossa; Paola Altieri; Gianmarco Rosa; Giovanni Spinella; Domenico Palombo; Razvan Arsenescu; Violeta Arsenescu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

6.  Predictors of weight loss in young adults who are over-weight or obese and have psychosocial problems: a post hoc analysis.

Authors:  Jørgen Lous; Kirsten S Freund
Journal:  BMC Fam Pract       Date:  2016-04-11       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.